J
John T. Wei
Researcher at University of Michigan
Publications - 395
Citations - 32685
John T. Wei is an academic researcher from University of Michigan. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 82, co-authored 385 publications receiving 30140 citations. Previous affiliations of John T. Wei include Johns Hopkins University & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Contemporary epidemiology of bladder exstrophy in the united states
TL;DR: Bladder exstrophy is rare, occurs in equal numbers of live male and female newborns, and is associated with certain co-morbid conditions, and incidence appears to be stable through time.
Journal ArticleDOI
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the canary prostate active surveillance study
Daniel W. Lin,Daniel W. Lin,Lisa F. Newcomb,Lisa F. Newcomb,Elissa C. Brown,James D. Brooks,Peter R. Carroll,Ziding Feng,Martin E. Gleave,Raymond S. Lance,Martin G. Sanda,Ian M. Thompson,John T. Wei,Peter S. Nelson +13 more
TL;DR: For men on active surveillance, both PCA3 and TMPRSS2:ERG seem to stratify the risk of having aggressive cancer as defined by tumor volume or Gleason score.
Journal ArticleDOI
The Role of Sarcosine Metabolism in Prostate Cancer Progression
Amjad Khan,Thekkelnaycke M. Rajendiran,Bushra Ateeq,Irfan A. Asangani,Jyoti N. Athanikar,Anastasia K. Yocum,Rohit Mehra,Javed Siddiqui,Ganesh S. Palapattu,John T. Wei,George Michailidis,Arun Sreekumar,Arul M. Chinnaiyan +12 more
TL;DR: Sarcosine levels were significantly elevated in PCa urine sediments compared to controls, and GNMT knockdown or SARDH overexpression in PCA xenografts inhibited tumor growth, substantiate the role of sarcosine inPCa progression.
Journal ArticleDOI
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
Aruna V. Sarma,John T. Wei +1 more
TL;DR: Lower urinary tract symptoms affect more than half of older men and options for bothersome symptoms include α-adrenergic-receptor blockers, 5α-reductase inhibitors, phosphodiesterase-5 inhibitor therapy, and antimuscarinic therapy.
Journal ArticleDOI
Nocturia and Quality of Life: Results from the Boston Area Community Health Survey
Varant Kupelian,John T. Wei,Michael P. O'Leary,Jens Peter Nørgaard,Raymond C. Rosen,John B. McKinlay +5 more
TL;DR: Nocturia is associated with decreased QOL and with an increased prevalence of depressive symptoms in both men and women and among women who reported sleep interference due to urologic symptoms, nocturia was associated with a threefold increase in odds of depression.